Published in Br Heart J on April 01, 1994
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ (1996) 2.43
Impact of psychotropic drugs on QT interval dispersion in adult patients. Arq Bras Cardiol (2014) 1.12
Comparison of automatic QT measurement techniques in the normal 12 lead electrocardiogram. Br Heart J (1995) 1.01
Measuring QT dispersion: man versus machine. Heart (1997) 0.96
Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects. Heart (1996) 0.95
Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart (2002) 0.92
Measurement and regulation of cardiac ventricular repolarization: from the QT interval to repolarization morphology. Philos Trans A Math Phys Eng Sci (2009) 0.91
Defective recovery of QT dispersion following transcatheter aortic valve implantation: frequency, predictors and prognosis. J Geriatr Cardiol (2015) 0.90
Relationship between QT interval dispersion in acute stroke and stroke prognosis: a systematic review. J Stroke Cerebrovasc Dis (2014) 0.85
A novel surface electrocardiogram-based marker of ventricular arrhythmia risk in patients with ischemic cardiomyopathy. J Am Heart Assoc (2012) 0.83
Measurement error as a source of QT dispersion: a computerised analysis. Heart (1998) 0.82
Dataset of manually measured QT intervals in the electrocardiogram. Biomed Eng Online (2006) 0.80
Vectorcardiographic recordings of the Q-T interval in a pediatric long Q-T syndrome population. Pediatr Cardiol (2012) 0.77
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
Ventricular repolarization measures for arrhythmic risk stratification. World J Cardiol (2016) 0.76
Earliest time of change in QT dispersion after stenting in patients with single vessel coronary artery disease. Int J Angiol (2007) 0.75
Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly? Tex Heart Inst J (2003) 0.75
How accurately can QT interval be measured in newborn infants? Eur J Pediatr (2003) 0.75
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J (1990) 4.28
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation (1992) 2.43
Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol (1985) 1.83
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation (1987) 1.81
QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J (1992) 1.70
Electrocardiographic quantitation of ventricular repolarization. Circulation (1989) 1.65
Sequence of epicardial repolarisation and configuration of the T wave. Br Heart J (1988) 1.53
New algorithm for QT interval analysis in 24-hour Holter ECG: performance and applications. Med Biol Eng Comput (1990) 1.36
Measurement of the QT interval. Eur Heart J (1985) 1.25
Errors in the visual determination of corrected QT (QTc) interval during acute myocardial infarction. J Am Coll Cardiol (1985) 1.14
Behavior of the terminal T wave during exercise in normal subjects, patients with symptomatic coronary artery disease and apparently healthy subjects with abnormal ST segment depression. J Am Coll Cardiol (1985) 1.11
Prolonged repolarization: a historical perspective. Am Heart J (1985) 1.01
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J (1990) 4.28
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet (1993) 2.73
Importance of lead selection in QT interval measurement. Am J Cardiol (1988) 2.23
107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord (2003) 2.12
The apex cardiogram and its relationship to haemodynamic events within the left heart. Br Heart J (1965) 2.02
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
The disease complex of the gypsy moth. I. Major components. J Invertebr Pathol (1971) 1.87
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J (1992) 1.70
QT dispersion. Br Heart J (1994) 1.62
Radiofrequency ablation for post infarction ventricular tachycardia. Report of a single centre experience of 112 cases. Eur Heart J (2002) 1.53
Sequence of epicardial repolarisation and configuration of the T wave. Br Heart J (1988) 1.53
Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J (1991) 1.50
Radiofrequency ablation of haemodynamically unstable ventricular tachycardia after myocardial infarction. Heart (2000) 1.48
European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace (2012) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Drug therapy for coronary heart disease: the Sheffield table. Lancet (1998) 1.43
Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction. Br Heart J (1995) 1.40
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? J Cardiovasc Electrophysiol (1999) 1.39
The response of paediatric arrhythmias to intravenous and oral flecainide. Br Heart J (1987) 1.39
ESCWGA/NASPE/P experts consensus statement: living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. Working Group of Arrhythmias of the European Society of Cardiology. North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (1999) 1.37
Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function. Br Heart J (1990) 1.28
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Lancet (1975) 1.25
Measurement of the QT interval. Eur Heart J (1985) 1.25
QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J (1995) 1.24
Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother (1999) 1.19
Evaluation of the left ventricle in patients with mitral stenosis. Circulation (1966) 1.18
Atrial fibrillation in the preexcitation syndrome. Am J Cardiol (1977) 1.18
Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J (1981) 1.13
Cryosurgical ablation of accessory atrioventricular connections: a method for correction of the pre-excitation syndrome. Circulation (1977) 1.12
Life at a price: the implantable defibrillator. Br Heart J (1990) 1.12
Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers. Br J Clin Pharmacol (1995) 1.07
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation (1985) 1.07
Is ventricular ectopy a legitimate target for ablation? Br Heart J (1994) 1.06
Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group. Br Heart J (1976) 1.04
High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation (1993) 1.03
Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients. Heart (2005) 1.02
Comparison of four techniques for recognition of ventricular fibrillation from the surface ECG. Med Biol Eng Comput (1993) 1.02
Comparison of automatic QT measurement techniques in the normal 12 lead electrocardiogram. Br Heart J (1995) 1.01
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion. J Clin Pathol (1983) 1.00
Temporary, catheter-induced block in accessory pathways. Circulation (1978) 0.97
A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J Cardiovasc Pharmacol (1986) 0.97
Rapid intravenous administration of granisetron prior to chemotherapy is not arythmogenic: results of a pilot study. Eur J Cancer (2003) 0.96
Measuring QT dispersion: man versus machine. Heart (1997) 0.96
Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects. Heart (1996) 0.95
Surgery for ventricular tachyarrhythmias based on fragmentation mapping in sinus rhythm alone. Eur J Cardiothorac Surg (1989) 0.93
Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol (1987) 0.93
Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. Acta Trop (1995) 0.92
His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy. Eur Heart J (1987) 0.91
Intercostal neuralgia associated with internal mammary artery grafting. Anaesthesia (1993) 0.91
Rickettsioses in Australia: isolation of Rickettsia tsutsugamushi and R. australis from naturally infected arthropods. Trans R Soc Trop Med Hyg (1974) 0.90
Quinacrine-resistant Giardia duodenalis. Parasitology (1996) 0.90
Amiodarone pulmonary toxicity: clinical and subclinical features. Q J Med (1986) 0.89
Antiarrhythmic drug effects on left ventricular performance. Eur Heart J (1987) 0.89
New catheter techniques for analysis of the sequence of retrograde atrial activation in man. Eur J Cardiol (1978) 0.89
Mexiletine. N Engl J Med (1987) 0.89
Long term treatment of ventricular arrhythmias with oral mexiletine. Postgrad Med J (1977) 0.87
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group. Am J Cardiol (1995) 0.87
Endocardial mapping of ventricular tachycardia in the intact human ventricle. III. Evidence of multiuse reentry with spontaneous and induced block in portions of reentrant path complex. J Am Coll Cardiol (1995) 0.87
Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias. Heart (1998) 0.87
Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. Q J Med (1993) 0.86
Recognition of ventricular fibrillation using neural networks. Med Biol Eng Comput (1994) 0.84
Queensland tick typhus in Sydney: a new endemic focus. Med J Aust (1979) 0.84
Implementation and Service error: Veterans Administration health care and the commercial market option. J Health Polit Policy Law (1981) 0.84
Chronic Mobitz type I second degree atrioventricular block. Has its importance been underestimated? Br Heart J (1985) 0.84
Characteristics of local electrograms with diastolic potentials: identification of different components of return pathways in ventricular tachycardia. J Interv Card Electrophysiol (1998) 0.84
Serological analysis of Rickettsia tsutsugamushi isolates from North Queensland. Aust J Exp Biol Med Sci (1982) 0.83
Coronary heart disease in high-risk populations: lessons from Finland. Eur Heart J (1990) 0.83
Survival in a case of life-threatening flecainide overdose. Intensive Care Med (1998) 0.83
Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction. J Cardiovasc Pharmacol (1980) 0.83
Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation. Heart (2005) 0.83
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence. Br Heart J (1995) 0.82
Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation (1977) 0.82
ACE inhibitors after myocardial infarction. N Engl J Med (1993) 0.82
Post-infarction communication between a left ventricular aneurysm and the right atrium. Eur Heart J (1992) 0.81
Ventricular arrhythmias after acute myocardial infarction treated with procainamide or mexiletine. Postgrad Med J (1977) 0.81
Arrhythmogenic right ventricular dysplasia: an uncommon cause of ventricular tachycardia in young and old? Br Heart J (1993) 0.81
Varicella myocarditis presenting with unusual ventricular arrhythmias. Br Heart J (1977) 0.81
Anaphylactic and reagin-like antibody in rats infected with Toxocara canis larvae. J Parasitol (1967) 0.81
Observations on mortality in lambs in Victoria associated with Eperythrozoon ovis. Aust Vet J (1971) 0.81
Evidence for electrical organization during ventricular fibrillation in the human heart. J Cardiovasc Electrophysiol (1995) 0.81
The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage. Drugs (1987) 0.80
Changes in the surface electrocardiogram during the onset of spontaneous ventricular fibrillation in man. Eur Heart J (1994) 0.80
Electrocardiographic features of septal location of right ventricular outflow tract tachycardia. Am J Cardiol (1997) 0.80